SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivanza Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

530057

INE984E01035

1.12525

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

7.64

EPS(TTM)

Face Value()

Div & Yield %

Back

Jubilant Pharmova consolidated net profit declines 44.60% in the December 2025 quarter

Feb 06,2026

Net profit of Jubilant Pharmova declined 44.60% to Rs 55.90 crore in the quarter ended December 2025 as against Rs 100.90 crore during the previous quarter ended December 2024. Sales rose 16.67% to Rs 2116.10 crore in the quarter ended December 2025 as against Rs 1813.70 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2116.10	1813.70	17
OPM %	13.68	15.83	-
PBDT	253.80	240.70	5
PBT	133.10	149.40	-11
NP	55.90	100.90	-45

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)